Catalyst Wire Dossier Catalyst Wire Dossier

Difluoromethylornithine (DFMO)

difluoromethylornithine
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Difluoromethylornithine (DFMO), covering 2014-07-30 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan [Phase 1]

See pricing